Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 331 - 340 of 449 for "Luxembourg" with applied filters

News & Analysis

Mathilde Ostertag appointed as new president of Ladies In Law Luxembourg Association (LILLA)

24 July 2019 by GSK

Mathilde Ostertag, Partner at GSK Stockmann Luxembourg, has been appointed as new president of LILLA – Ladies In Law Luxembourg Association. LILLA is the first network of its kind for women working within the legal sector in Luxembourg and was founded two years ago.

News & Analysis

The Parliament of Ukraine ratified the MLI Convention. Is this the end of offshores?

12 June 2019 by Taras Lytovchenko

BRIEFING: Kyiv, 12 June, 2019

News & Analysis

GSK Stockmann advised on the first real blockchain securities transaction

25 March 2019 by GSK

In mid-January 2019, GSK Stockmann advised on Germany’s first-ever issuance of securities originally carried out as a blockchain transaction. Commerzbank AG, Continental AG and Siemens AG were involved in the transaction.

News & Analysis

2019 M&A Report: Luxembourg

01 March 2019 by Marcus Peter, GSK Stockmann (Luxembourg)

2018 has once again shown a growing trend in M&A transactions with a view to Luxembourg-based target entities as well as acquisitions outside of Luxembourg that were started using a Luxembourg structure. Luxembourg-based targets are typically not the centre of high-profile M&A targets.

News & Analysis

Arendt Case Review #4 - December 2018 - Arendt Litigation Group

21 January 2019 by Arendt & Medernach - Luxembourg

BRIEFING: Luxembourg, 21 January, 2019

News & Analysis

Back to 2018 – Forward to 2019

21 January 2019 by Arendt & Medernach - Luxembourg

BRIEFING: Luxembourg, 21 January, 2019

News & Analysis

GSK Stockmann in Luxembourg advises China Merchants Bank on its launch of their first European-based investment fund

04 January 2019 by GSK

GSK Stockmann’s Luxembourg office has advised China Merchants Bank (CMB) on its launch of CMB Evergreen SA, SICAV-SIF, a Luxembourg investment fund and being the first European-based investment fund of CMB.

News & Analysis

Elias Neocleous & Co LLC strengthens its presence in Western Europe

03 January 2019 by Elias Neocleous & Co - Cyprus

BRIEFING: Limassol, 3 January, 2019

News & Analysis

IFLR 2018 M&A Report: Luxembourg

19 December 2018 by GSK Stockmann

IFLR 2018 M&A Report: Luxembourg

News & Analysis

GSK Stockmann appoints its first International Partner and elects new co-Managing Partner

12 December 2018 by GSK

At the end of November 2018, GSK Stockmann’s Partners elected Andreas Heinzmann as International Partner and Dr. Uwe Jäger as new co-Managing Partner. These nominations underpin GSK’s commitment to internationaliza-tion and the consistent implementation of the modernization course the firm set out on.